Use of thalidomide in the management of three HIV seroreactive children with Kaposi's sarcoma referred for palliative care.
Bunn
Mary R
MR
Umodzi Palliative Care, Queen Elizabeth Central Hospital, Blantyre. maryb@sdnp.org.mw
D000293:Adolescent; D020533:Angiogenesis Inhibitors / Q000627:therapeutic use*; D023241:Antiretroviral Therapy, Highly Active; D005260:Female; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D008297:Male; D010166:Palliative Care; D012514:Sarcoma, Kaposi / Q000188:drug therapy*; D013792:Thalidomide / Q000627:therapeutic use*; D016896:Treatment Outcome
D020533:Angiogenesis Inhibitors; D013792:Thalidomide